StemCells, Inc. (NASDAQ:STEM)

CAPS Rating: 2 out of 5

A biopharmaceutical company that operates in one segment, the development of novel cell-based therapeutics designed to treat human diseases and disorders.

Recs

2
Player Avatar G8BigBoom (67.83) Submitted: 3/17/2009 8:34:54 PM : Underperform Start Price: $17.90 STEM Score: +264.74

10 years down the road you will be kicking yourselves for not buying this. On second thought so will I. The technology has shown some very interesting Possible innovations. Talk only goes so far if you know what I mean. Stay clear for a few years with an ear to the news.

Report this Post 3 Replies
Member Avatar zzlangerhans (99.85) Submitted: 4/12/2011 11:10:01 PM
Recs: 0

Should I stay clear for a few years and then kick myself for not buying it? Seems kind of masochistic.

Member Avatar joaquingrech (97.80) Submitted: 5/5/2011 8:03:13 AM
Recs: 0

I think he wants you to kick yourself first, then stay clear for a few years. Then buy when it's high so you can enjoy the whole kicking yourself and staying clear again.

jokes aside, it's a horrible investment so far. I rated it 'outperform' out of love for the idea. No real $ on it at the moment, although I might if it keeps falling and the risk/reward ratio improves a lot. It's a shame so far it's only talk and not much actually done on this company.

Member Avatar G8BigBoom (67.83) Submitted: 6/19/2011 6:26:10 PM
Recs: 1

Wow, I never thought investors would be this stupid. It's not worth the risk but by all means I think you should sell the house and go all in. Being you can't read. Sometime in the future the technology will be huge but who says it will be this company.

I think I am dumber for just responding. Idiots

Featured Broker Partners


Advertisement